Biofrontera Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.018 million compared to USD 0.016 million a year ago. Revenue was USD 5.85 million compared to USD 4.46 million a year ago. Net loss was USD 9.84 million compared to USD 0.85 million a year ago. Basic loss per share from continuing operations was USD 7.23 compared to USD 0.9 a year ago. Diluted loss per share from continuing operations was USD 7.23 compared to USD 0.9 a year ago.
For the six months, sales was USD 0.036 million compared to USD 0.031 million a year ago. Revenue was USD 14.58 million compared to USD 14.21 million a year ago. Net loss was USD 17.32 million compared to net income of USD 4.71 million a year ago. Basic loss per share from continuing operations was USD 12.73 compared to basic earnings per share from continuing operations of USD 5.24 a year ago. Diluted loss per share from continuing operations was USD 12.73 compared to diluted earnings per share from continuing operations of USD 5.22 a year ago.